Disc Medicine stockholders elect three Class II directors, approve say-on-pay, ratify EY auditor

Disc Medicine, Inc.

Elected Georges Gemayel, Mark Chin, and Liam Ratcliffe as Class II directors for three-year term ending 2028.
Non-binding advisory vote approved executive compensation: 30,801,342 for, 235,453 against, 6,286 abstain.
Stockholders recommended say-on-pay vote every year; board adopted annual frequency until at least 2031.
Ratified Ernst & Young as independent registered public accounting firm for FY2025: 32,117,099 for, 2,370 against, 488 withheld.
All proposals passed with majority support; broker non-votes ranged from 1,076,876 on director elections to none on auditor ratification.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.